Here are links to view some of our recent Cell & Gene Therapy webinars.

Topic: Process Optimization Strategies for Successful MSC Therapy Development in Large-scale, Automated, and Closed Systems
Moderated by: Amanda Cinquin, PhD, Life Sciences Regulatory Affairs Manager, FUJIFILM Biosciences
Posted in: Cell & Gene Therapy

Cell therapy developers focused on regenerative medicine rely on human mesenchymal stromal/stem cells (MSCs) for their ability to expand and differentiate across a variety of cell types. In this panel discussion from Advanced Therapies Week 2025 with top experts in the field, we review the current challenges in MSC expansion, the importance of identifying and mitigating risks early, and key factors in optimizing the media and processes. 

Topic: Large-scale Expansion of Human Mesenchymal Stromal/Stem Cells
Presenter: Amaris Castanon, Field Application Scientist, FUJIFILM Biosciences
Posted in: Cell & Gene Therapy

Cell therapy developers focused on regenerative medicine rely on human mesenchymal stromal/stem cells (MSCs) for their ability to expand and differentiate across a variety of cell types. 

To generate high-quality MSCs in sufficient quantities for large-scale clinical trials, many cell therapy manufactures are moving from static to dynamic systems. MSC expansion in a closed sterile environment can help minimize risk of contamination, reduce production costs, and streamline the transition from research to clinical scale.

Topic: T Cell Expansion: Complete Workflow Solutions in Dynamic Cultivation Conditions
Presenter: Deborah LD. Maybruch, PhD, Field Application Scientist - Life Science Business Unit, FUJIFILM Biosciences
Posted in: Cell & Gene Therapy

Watch this presentation to learn more about the:

• Key considerations when selecting raw materials for cell culture media development
• The potential of chemically defined and serum-free cell culture media for T cell expansion
• Developing recombinant growth factors and cytokines for cell-based therapies
• Supplementing cell and tissue culture media in chemically defined settings
• T cell expansion in static and dynamic culture conditions

Topic: Making the Right Decision the First Time
Presenter: Marlin Frechette, Chief Quality and Compliance Officer (CQO), FUJIFILM Biosciences
Posted in: Cell & Gene Therapy

In this webinar recording, Marlin Frechette discusses:

• The critical factors in choosing the right raw materials for cell culture media development
• The quality attribute considerations for testing and quality controls of raw materials for cryopreservation media
• How to get the proper regulatory support from your supplier to ensure the safety and efficacy of the media
• Why a close partnership with your supplier can accelerate the development process all the way to therapy

Topic: Using Chemically-defined Media for Cell Culture
Presenter: Shahram Shahabi, MD, PhD, R&D Manager, Cell and Gene Therapy, FUJIFILM Biosciences
Posted in: Cell & Gene Therapy

In this webinar recording, Dr. Shahram Shahabi discusses how to avoid inconsistencies associated with standard cell culture media including: animal serum, ill-defined factors, batch-to-batch variability in composition, and the risk of contamination. 

This webinar will provide the insight to help you:

• Uncover the potential and benefits of chemically-defined (CD), serum-free cell culture media
• Discuss the scientific concerns about cell culturing with serum
• Discover how to make the switch from serum-based media to chemically-defined media

Topic: Three Key Factors in Cell Cryopreservation that Impact the Manufacturability of Cell & Gene Therapies
Presenter: Robert Newman, PhD, CSO, FUJIFILM Biosciences
Posted in: Cell & Gene Therapy

In this webinar recording, presented by Cell & Gene Therapy Insights, Robert Newman, PhD, CSO, FUJIFILM Biosciences, discusses:

• What are the key factors in cell cryopreservation, and why?
• The principles of cell cryopreservation as learned from immune cells and stem cells
• The importance of slow freezing of cryopreservation reagents, and related protocols for cell and gene therapy applications   
• The critical role that source materials play in quality of the final product

Topic: Solutions for Preparing Solutions
Speaker: Tom Fletcher, R&D Director, Process Sciences, FUJIFILM Biosciences
Posted in: Bioproduction / Cell & Gene Therapy

In this presentation, given at BPI EU 2021, Tom Fletcher, R&D Director, Process Sciences, introduces the new Manufacturing Science and Technology (MSAT) service, which was created in response to the needs of biopharmaceutical manufacturers for better cell culture media preparation methods. Whether the needs are to reduce cost, save time, or improve reliability, the MSAT service helps identify opportunities for practical improvement of existing solution preparation processes. Case studies are provided as examples of various approaches.

Topic: Solutions for Preparing Solutions
Speaker: Tom Fletcher, R&D Director, Process Sciences, FUJIFILM Biosciences
Posted in: Bioproduction / Cell & Gene Therapy

In this presentation, given at BPI EU 2021, Tom Fletcher, R&D Director, Process Sciences, introduces the new Manufacturing Science and Technology (MSAT) service, which was created in response to the needs of biopharmaceutical manufacturers for better cell culture media preparation methods. Whether the needs are to reduce cost, save time, or improve reliability, the MSAT service helps identify opportunities for practical improvement of existing solution preparation processes. Case studies are provided as examples of various approaches.

Session: Resolving Challenges in Cell Culture Media Preparation
Presenter: Michael De La Cruz, Senior Scientist, FUJIFILM Biosciences
Posted in: Bioproduction / Cell & Gene Therapy

Watch this webinar to learn how MSAT can improve your media preparation strategies, reduce hands-on time, and lower drug substance manufacturing costs.

Topic: Innovative Approaches for Selecting and Optimizing Versatile Chemically Defined Media
Presenter: Robert Newman, PhD, Chief Scientific Officer, FUJIFILM Biosciences
Posted in: Cell & Gene Therapy

At the 2021 Multi-Functional Cell Therapies (MFCT) Summit, Robert Newman, PhD, CSO, FUJIFILM Biosciences, presented innovative approaches that his R&D team uses to select and optimize versatile, chemically defined media, as well as how these efforts drive the successful development and production of combination biotherapies.

Topic: Raw Materials of Biological Origin: Navigating Regulatory Requirements for Cell Therapies
Presenter: Dominic Clarke, Global Head of Cell Therapy, HemaCare
Presenter: Marlin Frechette, Chief Quality & Compliance Officer, FUJIFILM Biosciences
Posted in: Cell & Gene Therapy

This webinar explores the specific regulatory requirements of different regions (including analysis of the amount of time the regulatory approval process takes in each case), and the critical quality attributes (CQAs) of cell therapy raw and starting materials.

Topic: Chemically Defined Media for T Cell-based Therapies. Regulatory and Technical Considerations
Presented by: Goncalo Regalo, PhD, Technical Application Scientist for Cell and Gene Therapy, FUJIFILM Biosciences Portugal
Presented by: Supriya Pokkali, PhD, Senior Scientist II, FUJIFILM Biosciences
Posted in: Cell & Gene Therapy

This webinar presents some technical considerations in the transition from serum containing to serum-free T cell workflows.

Topic: Cell culture media suppliers: regulatory considerations for advanced therapies
Speaker: Marlin Frechette, Corporate Compliance & Quality Officer (CQO), FUJIFILM Biosciences
Posted in: Cell & Gene Therapy

Learn more about how FUJIFILM Biosciences helps manufacturers through the raw materials qualification process and regional regulatory approvals, so that they can better address the challenges and opportunities on the road to bringing cell therapies to market.